COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: Results of a preliminary study

Archives of Gynecology and Obstetrics

Volumn 277, Issue 2, 2008, Pages 135-138

  Horn, Lars Christian ^a   Purz, Sandra ^a   Krumpe, Christine ^a   Bilek, Karl ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Breast; COX 2; Extramammary; Her 2 neu; Paget's disease; Steroid hormones; Vulva

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PAGET'S DISEASE, EXTRAMAMMARY; PAGET'S DISEASE, MAMMARY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; VULVAR NEOPLASMS;

EID: 37349013220     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-007-0434-1     Document Type: Article

References (23)

1. Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ (2004) COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 90:423-429
2. Brummer O, Stegner HE, Bohmer G, Kuhnle H, Petry KU (2004) HER-2/neu expression in Paget disease of the vulva and the female breast. Gynecol Oncol 95:336-340
3. Crawford D, Nimmo M, Clement PB, Thomson T, Benedet JL, Miller D, Gilks CB (1999) Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol 18:351-359
4. Davies G, Martin LA, Sacks N, Dowsett M (2002) Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention. Ann Oncol 13:669-678
5. De Potter CR, Schelfhout AM (1995) The neu-protein and breast cancer. Virchows Arch 426:107-115
6. Evans JF, Kargman SL (2004) Cancer and cyclooxygenase-2 (COX-2) inhibition. Curr Pharm Des 10:627-634
7. Fanning J, Lambert HC, Hale TM, Morris PC, Schuerch C (1999) Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol 180:24-27
8. Ferrandina G, Ranelletti FO, Salutari V, Gessi M, Legge F, Zannoni GF, Scambia G, Lauriola L (2004) Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions. Gynecol Oncol 92:537-544
9. Fishman DA, Chambers SK, Schwartz PE, Kohorn EI, Chambers JT (1995) Extramammary Paget's disease of the vulva. Gynecol Oncol 56:266-270
10. Fox H, Wells M (2003) Recent advances in the pathology of the vulva. Histopathology 42:209-216
11. Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC (2001) Molecular markers in Paget disease of the breast. J Surg Oncol 77:171-178
12. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ; Panel members (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569-1583
13. Half E, Ming Tang X, Gwyn K, Sahin A, Wathen K, Sinicrope FA (2002) Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62:1676-1681
14. Harris RE, Namboodiri KK, Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7:203-205
15. Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK (2005) Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12:391-397
16. Liegl B, Horn LC, Moinfar F (2005) Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Mod Pathol 18:1283-1288
17. Olson DJ, Fujimura M, Swanson P, Okagaki T (1991) Immunohistochemical features of Paget's disease of the vulva with and without adenocarcinoma. Int J Gynecol Pathol 10:285-295
18. Reich O, Liegl B, Tamussino K, Regauer S (2005) p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease. Mod Pathol 18:354-357
19. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637-2645
20. Tebes S, Cardosi R, Hoffman M (2002) Paget's disease of the vulva. Am J Obstet Gynecol 187:281-283
21. van Diest PJ, van Dam P, Henzen-Logmans SC (1997) A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. Clin Pathol 50: 801-804
22. Witton CJ, Hawe SJ, Cooke TG, Bartlett JM (2004) Cyclooxygenase-2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer. Histopathology 45:47-54
23. Zollo JD, Zeitouni NC (2000) The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 142:59-65